Medical Device 2012 - Medical Device Adverse Event Reporting and Vigilance System During Clinical Trials and Post-Marketing: US, EU, and Canada
Date2012-03-06
Deadline2012-03-06
VenuePalo Alto, USA - United States 
KeywordsAdverse Event Reporting; Medical Devices; Clinical Trials; Post-Marketing; medical device surveillance; vigilance system; CAC information; 21 CFR Part 820; ISO 13485;GHTF guidance
Topics/Call fo Papers
This 3-hr virtual seminar will discuss the requirements and compliance in medical device adverse event reporting and medical device surveillance/vigilance system in the US, Europe and Canada.
Why Should You Attend:
To be able to achieve sustainability and to remain sustainable and competitive in global medical device markets, it is necessary to streamline regulatory compliance processes, in particular, the Adverse Event (AE) Reporting during clinical studies and post-marketing.
Last modified: 2012-02-13 19:46:03
Share Your Research, Maximize Your Social Impacts

